Literature DB >> 4544784

Standardization of diagnostic materials. 3. Laboratory reagents and coagulation assay procedures.

E A Loeliger.   

Abstract

This paper reviews current methods of standardizing laboratory investigations in blood clotting, points out their shortcomings, and suggests ways of improving them. Procedures requiring standardization include the diagnosis of haemorrhagic diathesis and thrombotic tendency; the quantification of liver function; and monitoring of the effect of haemostatic replacement therapy and therapeutic anticoagulation. Care in collecting, storing, and handling blood for investigation is of primary importance. Achievements in the standardization of reagents are reviewed and examples of standardized methods are given. Although knowledge of the haemostatic process and experimental methods for its investigation have reached an advanced stage, their clinical application is still unsatisfactory owing to the inadequacy of national and international regulations. To improve the situation, one or more internationally approved laboratories for standardization and quality control, operating according to rules elaborated by experts in the field, should be designated in each country. The need for international reference laboratories is urgent.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4544784      PMCID: PMC2483061     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  55 in total

1.  The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin.

Authors:  P A OWREN; K AAS
Journal:  Scand J Clin Lab Invest       Date:  1951       Impact factor: 1.713

2.  Standardisation of heparin for clinical use.

Authors:  L B Jaques; L W Kavanagh
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

3.  Heparin from different sources.

Authors:  L B Jaques
Journal:  Lancet       Date:  1972-12-09       Impact factor: 79.321

4.  Comparison of anticoagulant activity of two preparations of purified heparin.

Authors:  B J Baltes; S Diamond; R J D'Agostino
Journal:  Clin Pharmacol Ther       Date:  1973 Mar-Apr       Impact factor: 6.875

5.  Calibration of five different thromboplastins, using fresh and freeze-dried plasma.

Authors:  D R Bangham; R Biggs; M Brozović; K W Denson
Journal:  Thromb Diath Haemorrh       Date:  1973-05-10

6.  Comparison of ethanol and protamine tests in demonstration of soluble fibrin and early products of fibrin degradation.

Authors:  Y P Konttinen; L Kemppainen; O Turunen
Journal:  Thromb Diath Haemorrh       Date:  1972-12-31

7.  Plasma free of factors II, VII, IX, and X. Need for high speed centrifugation after Al(OH) 3 absorption.

Authors:  E A Loeliger; L P van Halem-Visser; H C Hemker
Journal:  Thromb Diath Haemorrh       Date:  1973-02-28

8.  Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.

Authors:  O Castro; L R Farber; L P Clyne
Journal:  Ann Intern Med       Date:  1972-10       Impact factor: 25.391

9.  [Acquired factor IX-inhibitor in a non-hemophilic patient with autoimmune disease].

Authors:  R Largo; P Sigg; A von Felten; P W Straub
Journal:  Schweiz Med Wochenschr       Date:  1972-11-04

10.  Considerations on an international standard for the one-stage prothrombin time in the control of anticoagulant therapy.

Authors:  E A Loeliger; H C Hemker
Journal:  Thromb Diath Haemorrh Suppl       Date:  1968
View more
  1 in total

1.  [Quality control and standardization of prothrombin time determination for control of oral anticoagulants].

Authors:  E A Loeliger; C A Dijk-Wierda; J Roos
Journal:  Blut       Date:  1977-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.